ACETAZOLAMIDE

ACETAZOLAMIDE was reported 6147 times

ACETAZOLAMIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VITREOUS INCARCERATION 6 0.8571
1 SOMATOSTATIN RECEPTOR SCAN ABNORMAL 6 0.5455
2 HYPOTONY MACULOPATHY 17 0.4146
3 HAIR FOLLICLE TUMOUR BENIGN 41 0.3694
4 CONGENITAL EMPHYSEMA 8 0.3077
5 EXERTIONAL RHABDOMYOLYSIS 11 0.2973
6 RETINOPATHY SICKLE CELL 5 0.2778
7 BRAIN STEM MICROHAEMORRHAGE 6 0.2143
8 FAT EMBOLISM SYNDROME 9 0.1636
9 CEREBELLAR MICROHAEMORRHAGE 6 0.1538
10 NUMB CHIN SYNDROME 6 0.1132
11 CONGENITAL INTESTINAL MALFORMATION 13 0.1121
12 CHOROIDAL DETACHMENT 61 0.1099
13 CONGENITAL CEREBRAL CYST 12 0.1071
14 CHOROIDAL EFFUSION 78 0.0971
15 BURKHOLDERIA TEST POSITIVE 11 0.0887
16 CAPILLARITIS 22 0.0797
17 TOTAL LUNG CAPACITY ABNORMAL 30 0.0771
18 RETINOPATHY HAEMORRHAGIC 5 0.0758
19 ACID-BASE BALANCE DISORDER MIXED 5 0.0667
20 PULMONARY VASCULITIS 33 0.0613
21 ACUTE MYOPIA 11 0.0604
22 SPIROMETRY ABNORMAL 32 0.0535
23 MITE ALLERGY 33 0.0504
24 CONGENITAL HYPOTHYROIDISM 12 0.0465
25 OCULAR SURFACE DISEASE 13 0.0463
26 MACULAR DETACHMENT 11 0.0455
27 FLAT ANTERIOR CHAMBER OF EYE 8 0.0447
28 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 32 0.0437
29 CAVERNOUS SINUS THROMBOSIS 11 0.0433
30 DISSEMINATED BLASTOMYCOSIS 7 0.0409
31 HEPATOSPLENIC T-CELL LYMPHOMA 15 0.0404
32 IRIS NEOVASCULARISATION 5 0.0400
33 ANTERIOR CHAMBER DISORDER 9 0.0391
34 COMPLICATIONS OF BONE MARROW TRANSPLANT 14 0.0388
35 MYCOTIC ALLERGY 33 0.0386
36 HYPHAEMA 20 0.0383
37 DUST ALLERGY 33 0.0336
38 JOINT SPACE NARROWING 10 0.0336
39 NON-CARDIOGENIC PULMONARY OEDEMA 35 0.0331
40 SINGLE UMBILICAL ARTERY 12 0.0325
41 ANGLE CLOSURE GLAUCOMA 81 0.0317
42 CORNEAL DECOMPENSATION 5 0.0311
43 VOLVULUS OF SMALL BOWEL 6 0.0305
44 IDIOPATHIC INTRACRANIAL HYPERTENSION 66 0.0293
45 OPHTHALMIC VEIN THROMBOSIS 7 0.0289
46 ACIDOSIS HYPERCHLORAEMIC 17 0.0286
47 LARYNGEAL OBSTRUCTION 5 0.0273
48 SHORT STATURE 7 0.0267
49 OPEN ANGLE GLAUCOMA 16 0.0261
50 TUMOUR ULCERATION 6 0.0253
51 HYPOTONY OF EYE 10 0.0238
52 CONJUNCTIVITIS ALLERGIC 34 0.0229
53 CRYSTALLURIA 12 0.0221
54 NEURITIS 33 0.0214
55 BLOOD CORTICOTROPHIN INCREASED 6 0.0208
56 INTRAOCULAR PRESSURE DECREASED 10 0.0190
57 CSF PRESSURE INCREASED 5 0.0188
58 HYPERCALCIURIA 9 0.0183
59 SYMPTOM MASKED 13 0.0179
60 FOETAL HEART RATE DECELERATION ABNORMALITY 12 0.0170
61 CORNEAL OEDEMA 38 0.0169
62 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 34 0.0167
63 IRIS ADHESIONS 8 0.0156
64 DROPPED HEAD SYNDROME 6 0.0152
65 CENTRAL HYPOTHYROIDISM 5 0.0151
66 INTRACRANIAL PRESSURE INCREASED 84 0.0151
67 PAPILLOEDEMA 66 0.0146
68 NEONATAL TACHYPNOEA 6 0.0145
69 RHINOCEREBRAL MUCORMYCOSIS 5 0.0144
70 CLEAR CELL RENAL CELL CARCINOMA 10 0.0144
71 BENIGN INTRACRANIAL HYPERTENSION 18 0.0143
72 OVERLAP SYNDROME 10 0.0143
73 TOXIC LEUKOENCEPHALOPATHY 10 0.0138
74 DRUG CLEARANCE DECREASED 18 0.0138
75 CATARACT SUBCAPSULAR 8 0.0131
76 ALKALOSIS 5 0.0131
77 DISABILITY ASSESSMENT SCALE SCORE INCREASED 4 0.0130
78 CEREBRAL VENOUS SINUS THROMBOSIS 11 0.0130
79 ACUTE CHEST SYNDROME 11 0.0125
80 INTELLECTUAL DISABILITY 19 0.0125
81 USE OF ACCESSORY RESPIRATORY MUSCLES 5 0.0121
82 CARDIAC ANEURYSM 12 0.0121
83 INTRAOCULAR PRESSURE INCREASED 150 0.0117
84 NORMOCHROMIC NORMOCYTIC ANAEMIA 35 0.0116
85 MYASTHENIC SYNDROME 9 0.0116
86 OCULAR HYPERTENSION 22 0.0113
87 FORCED EXPIRATORY VOLUME DECREASED 32 0.0113
88 CEREBRAL MICROHAEMORRHAGE 5 0.0110
89 CERVICAL CORD COMPRESSION 4 0.0110
90 HYPERCAPNIA 33 0.0109
91 RESPIRATORY SYMPTOM 31 0.0109
92 METABOLIC ALKALOSIS 17 0.0106
93 SECONDARY ADRENOCORTICAL INSUFFICIENCY 16 0.0106
94 GRUNTING 6 0.0100
95 CORTISOL INCREASED 6 0.0096
96 RETINAL VASCULAR OCCLUSION 7 0.0094
97 DEATH NEONATAL 13 0.0093
98 INTRACRANIAL VENOUS SINUS THROMBOSIS 10 0.0093
99 RESPIRATORY ALKALOSIS 15 0.0092
100 CYSTOID MACULAR OEDEMA 17 0.0090
101 HYPOCHLORAEMIA 10 0.0085
102 MYOPIA 19 0.0080
103 INTRACRANIAL HYPOTENSION 5 0.0077
104 NEPHROCALCINOSIS 9 0.0076
105 CEREBROSPINAL FLUID LEAKAGE 14 0.0076
106 NEUROLOGICAL SYMPTOM 41 0.0072
107 SEROUS RETINAL DETACHMENT 6 0.0072
108 IRIDOCYCLITIS 22 0.0070
109 MESOTHELIOMA 9 0.0069
110 MACROCYTOSIS 8 0.0069
111 VITREOUS HAEMORRHAGE 19 0.0069
112 CEREBELLAR ATROPHY 6 0.0068
113 CONJUNCTIVAL OEDEMA 7 0.0068
114 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 9 0.0067
115 METABOLIC ACIDOSIS 213 0.0067
116 DYSMETRIA 4 0.0066
117 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 11 0.0066
118 PUNCTATE KERATITIS 6 0.0065
119 ASPIRATION PLEURAL CAVITY 5 0.0065
120 MULTIPLE-DRUG RESISTANCE 20 0.0064
121 PULMONARY ALVEOLAR HAEMORRHAGE 35 0.0062
122 CROSS SENSITIVITY REACTION 6 0.0062
123 RETINOPATHY 23 0.0062
124 VITH NERVE PARALYSIS 7 0.0061
125 IDIOSYNCRATIC DRUG REACTION 6 0.0061
126 OCULAR VASCULAR DISORDER 5 0.0061
127 POSTPARTUM HAEMORRHAGE 8 0.0059
128 CORNEAL OPACITY 8 0.0059
129 MEDICATION OVERUSE HEADACHE 5 0.0058
130 RETINAL TOXICITY 6 0.0058
131 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 6 0.0056
132 INTRA-UTERINE DEATH 9 0.0056
133 SEBORRHOEIC KERATOSIS 8 0.0055
134 ACCOMMODATION DISORDER 4 0.0055
135 ARTERIOSCLEROSIS CORONARY ARTERY 36 0.0054
136 CORNEAL DEPOSITS 4 0.0054
137 HYDROCEPHALUS 29 0.0053
138 DISSEMINATED CRYPTOCOCCOSIS 4 0.0053
139 OPTIC NEUROPATHY 11 0.0052
140 HYPERAMMONAEMIC ENCEPHALOPATHY 9 0.0052
141 RESPIRATORY ACIDOSIS 20 0.0051
142 RENAL TUBULAR ACIDOSIS 11 0.0050
143 PERICARDIAL HAEMORRHAGE 11 0.0050
144 OPTIC ATROPHY 8 0.0049
145 CONSCIOUSNESS FLUCTUATING 5 0.0048
146 CORNEAL DISORDER 10 0.0046
147 UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE 5 0.0045
148 GLAUCOMA 86 0.0045
149 MENINGITIS ASEPTIC 20 0.0045
150 COLOUR BLINDNESS 4 0.0044
151 NEUROLOGICAL DECOMPENSATION 10 0.0043
152 ALLODYNIA 5 0.0043
153 AORTIC ARTERIOSCLEROSIS 11 0.0043
154 LABILE BLOOD PRESSURE 5 0.0042
155 PNEUMONIA INFLUENZAL 5 0.0042
156 CHRONIC RESPIRATORY FAILURE 5 0.0041
157 ANTISOCIAL BEHAVIOUR 4 0.0040
158 IMMUNE RECONSTITUTION SYNDROME 5 0.0039
159 RETINAL DEGENERATION 5 0.0038
160 HYPERAMMONAEMIA 19 0.0038
161 KERATOPATHY 6 0.0038
162 PUPILLARY REFLEX IMPAIRED 7 0.0038
163 SCLERITIS 6 0.0037
164 ARTERIOSCLEROSIS 35 0.0037
165 CARBON DIOXIDE INCREASED 5 0.0037
166 IRITIS 11 0.0036
167 MENINGITIS 24 0.0036
168 BLOOD PRESSURE DIASTOLIC ABNORMAL 9 0.0035
169 CARBON DIOXIDE DECREASED 4 0.0035
170 VISUAL FIELD DEFECT 25 0.0035
171 OBSTRUCTIVE SLEEP APNOEA SYNDROME 5 0.0034
172 LYMPHOPROLIFERATIVE DISORDER 10 0.0034
173 ACIDOSIS 26 0.0034
174 ERYSIPELAS 17 0.0034
175 MYCOBACTERIUM AVIUM COMPLEX INFECTION 9 0.0033
176 FULL BLOOD COUNT ABNORMAL 35 0.0033
177 REBOUND ACID HYPERSECRETION 10 0.0033
178 EYE OEDEMA 8 0.0033
179 VITRITIS 6 0.0032
180 LEUKOENCEPHALOPATHY 12 0.0032
181 MYELOPATHY 6 0.0032
182 OBSTRUCTIVE AIRWAYS DISORDER 35 0.0031
183 CALCINOSIS 7 0.0031
184 ADJUSTMENT DISORDER 4 0.0031
185 HYPOVOLAEMIA 18 0.0031
186 DEAFNESS NEUROSENSORY 10 0.0030
187 NEPHROGENIC ANAEMIA 14 0.0030
188 VASCULITIS 35 0.0030
189 AMMONIA INCREASED 15 0.0029
190 RETINAL DETACHMENT 27 0.0029
191 DIABETES INSIPIDUS 7 0.0029
192 BLOOD CHLORIDE INCREASED 5 0.0029
193 BLOOD PRESSURE SYSTOLIC ABNORMAL 7 0.0028
194 MACULOPATHY 10 0.0028
195 CONJUNCTIVAL HYPERAEMIA 10 0.0028
196 HYPERPARATHYROIDISM SECONDARY 7 0.0028
197 RETINAL ARTERY OCCLUSION 7 0.0028
198 CEREBRAL ATROPHY 11 0.0028
199 CEREBRAL VENOUS THROMBOSIS 5 0.0028
200 BLEPHARITIS 11 0.0027
201 AUTONOMIC NERVOUS SYSTEM IMBALANCE 8 0.0027
202 PRE-EXISTING CONDITION IMPROVED 17 0.0027
203 HYPOKALAEMIA 125 0.0027
204 STILLBIRTH 13 0.0027
205 RETINAL DISORDER 7 0.0027
206 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 6 0.0027
207 RED CELL DISTRIBUTION WIDTH INCREASED 11 0.0026
208 HYPOREFLEXIA 5 0.0026
209 SOCIAL AVOIDANT BEHAVIOUR 15 0.0026
210 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 140 0.0025
211 ELECTROENCEPHALOGRAM ABNORMAL 8 0.0025
212 RETINAL HAEMORRHAGE 18 0.0025
213 EYELID PAIN 5 0.0025
214 EUGLYCAEMIC DIABETIC KETOACIDOSIS 10 0.0024
215 OPTIC NEURITIS 22 0.0024
216 HYPERVENTILATION 14 0.0024
217 INTRAVENTRICULAR HAEMORRHAGE 6 0.0024
218 NODULE 31 0.0024
219 TORTICOLLIS 5 0.0024
220 CARDIOPULMONARY FAILURE 9 0.0023
221 TOXIC EPIDERMAL NECROLYSIS 35 0.0023
222 ACUTE RESPIRATORY FAILURE 44 0.0023
223 TYPE I HYPERSENSITIVITY 8 0.0023
224 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 6 0.0023
225 SICKLE CELL ANAEMIA WITH CRISIS 35 0.0022
226 INFUSION SITE PRURITUS 7 0.0022
227 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 57 0.0022
228 UVEITIS 30 0.0022
229 BRAIN OPERATION 5 0.0022
230 CUSHINGOID 7 0.0022
231 THERAPY PARTIAL RESPONDER 34 0.0022
232 PARADOXICAL DRUG REACTION 8 0.0022
233 ENDOPHTHALMITIS 13 0.0022
234 ENDOTRACHEAL INTUBATION 6 0.0021
235 FOETAL GROWTH RESTRICTION 13 0.0021
236 BLOOD BICARBONATE DECREASED 4 0.0021
237 CARDIAC TAMPONADE 10 0.0021
238 VENTRICULAR SEPTAL DEFECT 12 0.0021
239 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 16 0.0021
240 CYTOMEGALOVIRUS CHORIORETINITIS 4 0.0020
241 ATAXIA 24 0.0020
242 HYPOXIA 71 0.0020
243 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 34 0.0020
244 CATHETER SITE HAEMORRHAGE 5 0.0020
245 KERATITIS 6 0.0020
246 CANCER PAIN 5 0.0020
247 FEELING OF DESPAIR 9 0.0019
248 TACHYPNOEA 26 0.0019
249 THROMBOCYTOSIS 7 0.0019
250 PULMONARY FIBROSIS 35 0.0018
251 ELECTROLYTE IMBALANCE 21 0.0018
252 OLIGOHYDRAMNIOS 6 0.0018
253 CHOLESTATIC LIVER INJURY 4 0.0018
254 CLOSTRIDIUM DIFFICILE COLITIS 19 0.0018
255 TOXIC ENCEPHALOPATHY 9 0.0018
256 VISUAL ACUITY REDUCED 59 0.0018
257 BLEPHAROSPASM 11 0.0017
258 MUSCLE CONTRACTIONS INVOLUNTARY 6 0.0017
259 PARALYSIS 24 0.0017
260 METABOLIC ENCEPHALOPATHY 5 0.0017
261 LUNG DISORDER 81 0.0017
262 THERAPY NON-RESPONDER 74 0.0016
263 CARDIAC FAILURE CHRONIC 7 0.0016
264 FACIAL PARALYSIS 14 0.0016
265 HORMONE LEVEL ABNORMAL 8 0.0016
266 INTRACARDIAC THROMBUS 5 0.0016
267 HYPOPHOSPHATAEMIA 12 0.0016
268 MACULAR OEDEMA 9 0.0016
269 FLANK PAIN 15 0.0016
270 RESPIRATORY RATE DECREASED 5 0.0016
271 END STAGE RENAL DISEASE 29 0.0016
272 INFUSION SITE SWELLING 10 0.0016
273 ENCEPHALOPATHY 39 0.0016
274 COMMUNICATION DISORDER 6 0.0016
275 DRUG RESISTANCE 40 0.0016
276 FOETAL DEATH 8 0.0015
277 PHOTOPHOBIA 29 0.0015
278 HAEMOPTYSIS 43 0.0015
279 PRODUCT ADMINISTRATION INTERRUPTED 12 0.0015
280 EYE OPERATION 7 0.0015
281 EXPOSURE VIA BREAST MILK 6 0.0015
282 ABORTION INDUCED 14 0.0015
283 INTESTINAL ISCHAEMIA 8 0.0015
284 ENCEPHALITIS 10 0.0014
285 HYPOTHYROIDISM 46 0.0014
286 EYE PAIN 81 0.0014
287 ATRIAL SEPTAL DEFECT 12 0.0014
288 INFUSION SITE ERYTHEMA 12 0.0014
289 BREATH SOUNDS ABNORMAL 7 0.0014
290 RESPIRATORY DISTRESS 39 0.0014
291 CEREBRAL THROMBOSIS 4 0.0014
292 GRAND MAL CONVULSION 13 0.0014
293 HAEMORRHAGIC DIATHESIS 5 0.0014
294 PYODERMA GANGRENOSUM 5 0.0014
295 EYE INFLAMMATION 13 0.0014
296 PERIPHERAL VASCULAR DISORDER 7 0.0014
297 POLYURIA 11 0.0013
298 THROMBOTIC MICROANGIOPATHY 13 0.0013
299 STATUS EPILEPTICUS 15 0.0013
300 NYSTAGMUS 7 0.0013
301 BRAIN NATRIURETIC PEPTIDE INCREASED 4 0.0013
302 INTERVERTEBRAL DISC DEGENERATION 12 0.0013
303 APHTHOUS ULCER 10 0.0013
304 DIPLOPIA 33 0.0013
305 BLOOD ALBUMIN DECREASED 10 0.0013
306 FOREIGN BODY SENSATION IN EYES 8 0.0013
307 OSTEOPENIA 19 0.0013
308 BLINDNESS 51 0.0013
309 HYPERVOLAEMIA 6 0.0012
310 HEREDITARY ANGIOEDEMA 13 0.0012
311 SPLENOMEGALY 14 0.0012
312 BRAIN OEDEMA 15 0.0012
313 COLITIS ISCHAEMIC 8 0.0012
314 CATARACT OPERATION 7 0.0012
315 SUBARACHNOID HAEMORRHAGE 12 0.0012
316 DIABETIC RETINOPATHY 4 0.0012
317 ESCHERICHIA URINARY TRACT INFECTION 5 0.0012
318 PETIT MAL EPILEPSY 6 0.0012
319 INCORRECT DRUG ADMINISTRATION RATE 5 0.0012
320 TUBULOINTERSTITIAL NEPHRITIS 22 0.0012
321 POOR VENOUS ACCESS 12 0.0012
322 OCULAR DISCOMFORT 13 0.0012
323 RIGHT VENTRICULAR FAILURE 8 0.0011
324 DEPRESSIVE SYMPTOM 4 0.0011
325 BLINDNESS UNILATERAL 16 0.0011
326 EYE DISORDER 37 0.0011
327 RESPIRATORY FAILURE 81 0.0011
328 DELIRIUM 38 0.0011
329 BLOOD PRESSURE DIASTOLIC INCREASED 5 0.0011
330 STEVENS-JOHNSON SYNDROME 24 0.0011
331 ARTHRITIS INFECTIVE 5 0.0011
332 SKIN ABRASION 5 0.0011
333 TENDERNESS 11 0.0011
334 SLEEP APNOEA SYNDROME 20 0.0010
335 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 10 0.0010
336 CONJUNCTIVAL HAEMORRHAGE 4 0.0010
337 ANURIA 9 0.0010
338 HYPOVOLAEMIC SHOCK 5 0.0010
339 MATERNAL DRUGS AFFECTING FOETUS 8 0.0010
340 HAEMOLYSIS 8 0.0010
341 ATELECTASIS 10 0.0010
342 FOETAL EXPOSURE DURING PREGNANCY 84 0.0010
343 GASTROENTERITIS 15 0.0010
344 VITAMIN D DEFICIENCY 10 0.0010
345 URINE ODOUR ABNORMAL 6 0.0010
346 PSYCHOTIC DISORDER 30 0.0010
347 ATRIAL FLUTTER 8 0.0010
348 HYPOTONIA 10 0.0010
349 AZOTAEMIA 4 0.0010
350 DEFAECATION URGENCY 7 0.0010
351 HYPERKALAEMIA 35 0.0010
352 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 52 0.0010
353 HEPATOCELLULAR INJURY 14 0.0010
354 PRODUCTIVE COUGH 47 0.0010
355 EYE HAEMORRHAGE 13 0.0010
356 CATARACT 58 0.0010
357 REBOUND EFFECT 11 0.0010
358 INFUSION SITE EXTRAVASATION 6 0.0010
359 CONDITION AGGRAVATED 293 0.0010
360 PNEUMONIA ASPIRATION 24 0.0010
361 PARTIAL SEIZURES 5 0.0010
362 ACUTE KIDNEY INJURY 146 0.0010
363 VISUAL IMPAIRMENT 115 0.0009
364 LACTIC ACIDOSIS 30 0.0009
365 COGNITIVE DISORDER 43 0.0009
366 CONJUNCTIVITIS 17 0.0009
367 INSURANCE ISSUE 14 0.0009
368 FAECALOMA 5 0.0009
369 RENAL INJURY 27 0.0009
370 AUTISM SPECTRUM DISORDER 5 0.0009
371 HYPOKINESIA 13 0.0009
372 POST-TRAUMATIC STRESS DISORDER 6 0.0009
373 AFFECTIVE DISORDER 7 0.0009
374 PNEUMOTHORAX 14 0.0009
375 SLUGGISHNESS 9 0.0009
376 LOW BIRTH WEIGHT BABY 7 0.0009
377 IMPAIRED GASTRIC EMPTYING 12 0.0009
378 IMPAIRED DRIVING ABILITY 10 0.0009
379 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 42 0.0009
380 PNEUMONIA BACTERIAL 8 0.0009
381 CHRONIC KIDNEY DISEASE 66 0.0009
382 LYMPHOEDEMA 6 0.0009
383 MYASTHENIA GRAVIS 7 0.0009
384 EYE DISCHARGE 9 0.0009
385 PERSONALITY CHANGE 8 0.0009
386 INFUSION SITE PAIN 11 0.0009
387 HYPERAESTHESIA 7 0.0009
388 EPILEPSY 26 0.0008
389 PRODUCT USE IN UNAPPROVED INDICATION 210 0.0008
390 GENERALISED TONIC-CLONIC SEIZURE 14 0.0008
391 HEART RATE IRREGULAR 19 0.0008
392 DRUG INTERACTION 133 0.0008
393 LIVE BIRTH 7 0.0008
394 OFF LABEL USE 732 0.0008
395 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 59 0.0008
396 NEPHROLITHIASIS 38 0.0008
397 TOOTH FRACTURE 9 0.0008
398 BLINDNESS TRANSIENT 6 0.0008
399 PSYCHIATRIC SYMPTOM 6 0.0008
400 VISION BLURRED 111 0.0008
401 SCOLIOSIS 5 0.0008
402 IMMUNOSUPPRESSION 7 0.0008
403 WHEEZING 47 0.0008
404 SEIZURE 91 0.0008
405 SCREAMING 5 0.0008
406 MYDRIASIS 10 0.0008
407 MULTIPLE ORGAN DYSFUNCTION SYNDROME 22 0.0008
408 LEUKOCYTOSIS 14 0.0008
409 TREATMENT FAILURE 64 0.0008
410 HYPERGLYCAEMIA 28 0.0008
411 TORSADE DE POINTES 6 0.0008
412 PARAESTHESIA 120 0.0008
413 PULMONARY ARTERIAL HYPERTENSION 11 0.0008
414 BACTERAEMIA 9 0.0008
415 TRICUSPID VALVE INCOMPETENCE 6 0.0008
416 APPETITE DISORDER 5 0.0008
417 BRADYCARDIA 40 0.0008
418 BLOOD PRESSURE FLUCTUATION 18 0.0007
419 NEUROTOXICITY 13 0.0007
420 BEHAVIOUR DISORDER 4 0.0007
421 BIPOLAR DISORDER 8 0.0007
422 PRODUCT PRESCRIBING ISSUE 16 0.0007
423 CARDIOMEGALY 9 0.0007
424 EYE MOVEMENT DISORDER 5 0.0007
425 SOMNOLENCE 147 0.0007
426 RENAL IMPAIRMENT 61 0.0007
427 DEAFNESS UNILATERAL 4 0.0007
428 DROOLING 5 0.0007
429 RENAL TUBULAR NECROSIS 7 0.0007
430 SKIN INFECTION 8 0.0007
431 ACUTE PULMONARY OEDEMA 4 0.0007
432 ACUTE MYOCARDIAL INFARCTION 21 0.0007
433 MUSCLE ATROPHY 9 0.0007
434 DELUSION 11 0.0007
435 BRAIN FOG 11 0.0007
436 PRESCRIBED UNDERDOSE 14 0.0007
437 DRUG-INDUCED LIVER INJURY 22 0.0007
438 BLOOD POTASSIUM DECREASED 21 0.0007
439 CYTOKINE RELEASE SYNDROME 14 0.0007
440 TREATMENT NONCOMPLIANCE 38 0.0007
441 MUSCLE TWITCHING 16 0.0007
442 DRUG INTOLERANCE 67 0.0007
443 PANIC REACTION 5 0.0007
444 ALTERED STATE OF CONSCIOUSNESS 15 0.0007
445 PULMONARY OEDEMA 31 0.0007
446 PERICARDIAL EFFUSION 16 0.0007
447 MIGRAINE 66 0.0007
448 MENTAL STATUS CHANGES 19 0.0007
449 BRADYKINESIA 4 0.0007
450 BLOOD PRESSURE DIASTOLIC DECREASED 5 0.0007
451 TINNITUS 31 0.0007
452 OCULAR HYPERAEMIA 32 0.0007
453 PLEURAL EFFUSION 41 0.0007
454 ORAL PAIN 15 0.0007
455 BLOOD PRESSURE SYSTOLIC INCREASED 13 0.0007
456 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 5 0.0007
457 IRRITABILITY 40 0.0007
458 DRUG LEVEL INCREASED 11 0.0007
459 PAROSMIA 5 0.0007
460 PEMPHIGOID 5 0.0007
461 LETHARGY 38 0.0007
462 ADRENAL INSUFFICIENCY 8 0.0007
463 DERMATITIS ACNEIFORM 4 0.0007
464 HAEMODYNAMIC INSTABILITY 5 0.0007
465 BRAIN NEOPLASM 6 0.0007
466 RESPIRATORY TRACT INFECTION 17 0.0007
467 INCREASED TENDENCY TO BRUISE 6 0.0007
468 DISEASE RECURRENCE 31 0.0007
469 IRON DEFICIENCY ANAEMIA 6 0.0006
470 DRUG EXPOSURE DURING PREGNANCY 22 0.0006
471 THROMBOSIS 52 0.0006
472 CONCUSSION 5 0.0006
473 EXPOSURE DURING PREGNANCY 40 0.0006
474 HEPATIC ENCEPHALOPATHY 6 0.0006
475 APNOEA 5 0.0006
476 OXYGEN SATURATION DECREASED 36 0.0006
477 PULMONARY HAEMORRHAGE 5 0.0006
478 SEASONAL ALLERGY 9 0.0006
479 TOXICITY TO VARIOUS AGENTS 107 0.0006
480 RENAL FAILURE 84 0.0006
481 RASH MACULO-PAPULAR 14 0.0006
482 PULMONARY HYPERTENSION 13 0.0006
483 OBSESSIVE-COMPULSIVE DISORDER 5 0.0006
484 CARDIO-RESPIRATORY ARREST 26 0.0006
485 AGGRESSION 31 0.0006
486 LIVER FUNCTION TEST ABNORMAL 18 0.0006
487 FRUSTRATION TOLERANCE DECREASED 5 0.0006
488 MITRAL VALVE INCOMPETENCE 7 0.0006
489 MOUTH ULCERATION 13 0.0006
490 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 18 0.0006
491 BRADYPHRENIA 4 0.0006
492 BODY TEMPERATURE DECREASED 6 0.0006
493 SHOCK 14 0.0006
494 BEDRIDDEN 8 0.0006
495 CONFUSIONAL STATE 98 0.0006
496 DISORIENTATION 24 0.0006
497 FACE OEDEMA 10 0.0006
498 COVID-19 PNEUMONIA 7 0.0006
499 DYSKINESIA 24 0.0006
500 RENAL FAILURE ACUTE 25 0.0006
501 HYPONATRAEMIA 33 0.0006
502 TRANSAMINASES INCREASED 13 0.0006
503 DYSPNOEA EXERTIONAL 22 0.0006
504 DIABETIC KETOACIDOSIS 14 0.0006
505 DRY EYE 29 0.0006
506 URINE OUTPUT DECREASED 5 0.0006
507 SCRATCH 6 0.0006
508 DISSEMINATED INTRAVASCULAR COAGULATION 8 0.0006
509 PANCREATITIS 30 0.0006
510 SLEEP DISORDER 40 0.0006
511 EAR PAIN 11 0.0006
512 LYMPHOPENIA 8 0.0006
513 HEAD DISCOMFORT 10 0.0006
514 TYPE 2 DIABETES MELLITUS 19 0.0006
515 CYST 7 0.0006
516 SYSTEMIC LUPUS ERYTHEMATOSUS 20 0.0006
517 HYPOTENSION 113 0.0006
518 DEHYDRATION 75 0.0006
519 LIVER FUNCTION TEST INCREASED 12 0.0006
520 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 4 0.0006
521 CARDIOGENIC SHOCK 8 0.0006
522 HAEMATOCRIT DECREASED 11 0.0006
523 PREGNANCY 11 0.0005
524 DISEASE PROGRESSION 65 0.0005
525 CARDIAC FAILURE CONGESTIVE 44 0.0005
526 BLOOD GLUCOSE FLUCTUATION 6 0.0005
527 BALANCE DISORDER 47 0.0005
528 ANOREXIA 7 0.0005
529 RED BLOOD CELL SEDIMENTATION RATE INCREASED 6 0.0005
530 TASTE DISORDER 11 0.0005
531 UPPER RESPIRATORY TRACT INFECTION 25 0.0005
532 CEREBRAL DISORDER 4 0.0005
533 COAGULOPATHY 9 0.0005
534 BLOOD UREA INCREASED 9 0.0005
535 CANDIDA INFECTION 9 0.0005
536 CHROMATURIA 12 0.0005
537 EYE INFECTION 6 0.0005
538 DYSARTHRIA 20 0.0005
539 PULMONARY CONGESTION 7 0.0005
540 LACRIMATION INCREASED 16 0.0005
541 ECONOMIC PROBLEM 8 0.0005
542 EAR INFECTION 14 0.0005
543 MICTURITION URGENCY 6 0.0005
544 DRUG INEFFECTIVE 691 0.0005
545 HALLUCINATION, VISUAL 11 0.0005
546 POST PROCEDURAL COMPLICATION 10 0.0005
547 OEDEMA 28 0.0005
548 SPINAL PAIN 6 0.0005
549 PERIPHERAL COLDNESS 7 0.0005
550 ARTERIAL OCCLUSIVE DISEASE 4 0.0005
551 CYANOSIS 8 0.0005
552 VITREOUS FLOATERS 5 0.0005
553 SEPTIC SHOCK 22 0.0005
554 PULMONARY EMBOLISM 48 0.0005
555 ASTHMA 57 0.0005
556 MYOCLONUS 6 0.0005
557 NECK PAIN 28 0.0005
558 URINARY TRACT INFECTION 85 0.0005
559 SEDATION 13 0.0005
560 GASTRITIS 13 0.0005
561 HYPOTHERMIA 5 0.0005
562 MUSCLE TIGHTNESS 8 0.0005
563 EYELID PTOSIS 5 0.0005
564 CEREBRAL INFARCTION 12 0.0005
565 RESPIRATORY DEPRESSION 6 0.0005
566 AGRANULOCYTOSIS 9 0.0005
567 BLOOD ALKALINE PHOSPHATASE INCREASED 12 0.0005
568 COMA 23 0.0005
569 FLUID OVERLOAD 7 0.0005
570 THERAPEUTIC RESPONSE DECREASED 29 0.0005
571 DRUG EFFECT LESS THAN EXPECTED 7 0.0005
572 CYSTITIS 15 0.0005
573 ASPARTATE AMINOTRANSFERASE INCREASED 25 0.0005
574 HYPOPHAGIA 12 0.0005
575 UNRESPONSIVE TO STIMULI 12 0.0005
576 DECREASED ACTIVITY 5 0.0005
577 AMNESIA 30 0.0005
578 CARDIAC ARREST 38 0.0005
579 HEADACHE 287 0.0005
580 ASPIRATION 5 0.0005
581 CONVULSION 26 0.0005
582 INJECTION SITE NODULE 5 0.0005
583 HYPERSOMNIA 13 0.0005
584 MUSCULOSKELETAL CHEST PAIN 7 0.0005
585 DYSPNOEA 256 0.0005
586 SPINAL FRACTURE 9 0.0004
587 NERVOUS SYSTEM DISORDER 14 0.0004
588 MENINGIOMA 7 0.0004
589 MALNUTRITION 5 0.0004
590 FEAR 12 0.0004
591 NEPHROPATHY TOXIC 5 0.0004
592 BLOOD CALCIUM DECREASED 5 0.0004
593 PRODUCT TASTE ABNORMAL 6 0.0004
594 GASTROINTESTINAL HAEMORRHAGE 37 0.0004
595 HEAD INJURY 14 0.0004
596 ATRIAL FIBRILLATION 43 0.0004
597 RESPIRATORY TRACT CONGESTION 7 0.0004
598 RESTLESSNESS 16 0.0004
599 LOSS OF CONSCIOUSNESS 56 0.0004
600 CARDIAC FAILURE 35 0.0004
601 MEDICATION ERROR 24 0.0004
602 CONTRAINDICATED PRODUCT ADMINISTERED 13 0.0004
603 ANXIETY 121 0.0004
604 VENTRICULAR TACHYCARDIA 7 0.0004
605 ALANINE AMINOTRANSFERASE INCREASED 26 0.0004
606 HYPOCALCAEMIA 8 0.0004
607 INTENTIONAL PRODUCT USE ISSUE 37 0.0004
608 MUSCULOSKELETAL STIFFNESS 37 0.0004
609 PSYCHOMOTOR HYPERACTIVITY 7 0.0004
610 SPEECH DISORDER 22 0.0004
611 SINUSITIS 43 0.0004
612 SUBDURAL HAEMATOMA 6 0.0004
613 MACULAR DEGENERATION 5 0.0004
614 WRIST FRACTURE 5 0.0004
615 ANGER 14 0.0004
616 HEART RATE INCREASED 41 0.0004
617 LOCALISED INFECTION 10 0.0004
618 PRESCRIBED OVERDOSE 8 0.0004
619 FLUID RETENTION 21 0.0004
620 CRYING 15 0.0004
621 PRESYNCOPE 10 0.0004
622 NEURALGIA 10 0.0004
623 HAEMATURIA 14 0.0004
624 KIDNEY INFECTION 8 0.0004
625 RHABDOMYOLYSIS 17 0.0004
626 LIVER DISORDER 18 0.0004
627 TACHYCARDIA 36 0.0004
628 LIMB INJURY 11 0.0004
629 MUSCULAR WEAKNESS 46 0.0004
630 DEPRESSION 92 0.0004
631 GENERALISED OEDEMA 5 0.0004
632 IMMUNODEFICIENCY 6 0.0004
633 HEPATIC FUNCTION ABNORMAL 15 0.0004
634 INFECTION 58 0.0004
635 CORONARY ARTERY DISEASE 12 0.0004
636 FEELING COLD 11 0.0004
637 DEMENTIA 11 0.0004
638 DRY THROAT 4 0.0004
639 THIRST 7 0.0004
640 GASTROINTESTINAL DISORDER 35 0.0004
641 ELECTROCARDIOGRAM QT PROLONGED 14 0.0004
642 RIB FRACTURE 8 0.0004
643 ILLNESS 40 0.0004
644 GASTROENTERITIS VIRAL 7 0.0004
645 ANKLE FRACTURE 6 0.0004
646 RESTLESS LEGS SYNDROME 7 0.0004
647 BACK PAIN 89 0.0004
648 PRODUCT USE COMPLAINT 6 0.0004
649 DYSURIA 14 0.0004
650 IMMUNE SYSTEM DISORDER 5 0.0004
651 THERAPEUTIC RESPONSE UNEXPECTED 17 0.0004
652 FEBRILE NEUTROPENIA 25 0.0004
653 DYSSTASIA 11 0.0004
654 ABDOMINAL DISCOMFORT 63 0.0004
655 SURGERY 22 0.0004
656 BACTERIAL INFECTION 7 0.0004
657 MIDDLE INSOMNIA 7 0.0004
658 DECREASED APPETITE 87 0.0004
659 IRRITABLE BOWEL SYNDROME 8 0.0004
660 RHINORRHOEA 24 0.0004
661 MATERNAL EXPOSURE DURING PREGNANCY 33 0.0004
662 FIBROMYALGIA 9 0.0004
663 FRACTURE 7 0.0004
664 NEUROPATHY PERIPHERAL 35 0.0004
665 BACK INJURY 4 0.0004
666 BLOOD CREATININE INCREASED 24 0.0004
667 DRUG TOXICITY 5 0.0004
668 MOOD ALTERED 10 0.0004
669 HEPATIC FAILURE 11 0.0004
670 STAPHYLOCOCCAL INFECTION 12 0.0004
671 FALL 121 0.0004
672 CHEST PAIN 67 0.0004
673 EPISTAXIS 27 0.0004
674 HYPOMAGNESAEMIA 5 0.0004
675 ORAL HERPES 7 0.0004
676 PANCYTOPENIA 20 0.0004
677 MASS 5 0.0004
678 DRY MOUTH 29 0.0004
679 PANCREATITIS ACUTE 8 0.0004
680 TRANSIENT ISCHAEMIC ATTACK 12 0.0004
681 VOMITING 167 0.0004
682 HEMIPARESIS 6 0.0004
683 HYPOAESTHESIA 53 0.0004
684 DEPRESSED LEVEL OF CONSCIOUSNESS 14 0.0004
685 SINUS TACHYCARDIA 5 0.0004
686 GAIT DISTURBANCE 67 0.0003
687 EYE SWELLING 13 0.0003
688 ANAPHYLACTIC SHOCK 9 0.0003
689 INFLAMMATION 18 0.0003
690 GASTROOESOPHAGEAL REFLUX DISEASE 28 0.0003
691 COVID-19 61 0.0003
692 WEIGHT DECREASED 97 0.0003
693 PRODUCT PHYSICAL ISSUE 7 0.0003
694 BLOOD PRESSURE INCREASED 53 0.0003
695 PARAESTHESIA ORAL 5 0.0003
696 MYELODYSPLASTIC SYNDROME 5 0.0003
697 FEEDING DISORDER 7 0.0003
698 WEIGHT INCREASED 77 0.0003
699 BODY TEMPERATURE INCREASED 7 0.0003
700 PAIN IN EXTREMITY 101 0.0003
701 ACUTE RESPIRATORY DISTRESS SYNDROME 6 0.0003
702 PERITONITIS 7 0.0003
703 PRODUCT PRESCRIBING ERROR 8 0.0003
704 OROPHARYNGEAL PAIN 31 0.0003
705 DISTURBANCE IN ATTENTION 18 0.0003
706 PREMATURE BABY 10 0.0003
707 HALLUCINATION 25 0.0003
708 FATIGUE 258 0.0003
709 APHASIA 10 0.0003
710 THROMBOCYTOPENIA 37 0.0003
711 FUNGAL INFECTION 11 0.0003
712 PRODUCT USE ISSUE 62 0.0003
713 PANIC ATTACK 12 0.0003
714 VERTIGO 20 0.0003
715 AGITATION 24 0.0003
716 CYTOPENIA 4 0.0003
717 DEVICE RELATED INFECTION 5 0.0003
718 ABORTION SPONTANEOUS 13 0.0003
719 THINKING ABNORMAL 6 0.0003
720 HAEMOGLOBIN DECREASED 33 0.0003
721 ANAEMIA 61 0.0003
722 ARRHYTHMIA 15 0.0003
723 BLOOD PRESSURE DECREASED 21 0.0003
724 PALPITATIONS 37 0.0003
725 INTERNATIONAL NORMALISED RATIO INCREASED 9 0.0003
726 BLOOD LACTATE DEHYDROGENASE INCREASED 5 0.0003
727 DIZZINESS 157 0.0003
728 HALLUCINATION, AUDITORY 5 0.0003
729 PREMATURE DELIVERY 5 0.0003
730 NAUSEA 248 0.0003
731 WHITE BLOOD CELL COUNT INCREASED 12 0.0003
732 GLOSSODYNIA 7 0.0003
733 PYREXIA 108 0.0003
734 POLLAKIURIA 13 0.0003
735 ASTHENIA 117 0.0003
736 ABDOMINAL PAIN UPPER 64 0.0003
737 HERNIA 6 0.0003
738 SKIN ULCER 8 0.0003
739 HAEMORRHOIDS 6 0.0003
740 NERVOUSNESS 16 0.0003
741 DYSPHAGIA 29 0.0003
742 SEPSIS 34 0.0003
743 ANHEDONIA 8 0.0003
744 MULTIPLE FRACTURES 5 0.0003
745 URINARY INCONTINENCE 9 0.0003
746 PHOTOSENSITIVITY REACTION 5 0.0003
747 C-REACTIVE PROTEIN INCREASED 11 0.0003
748 BLOOD PRESSURE ABNORMAL 6 0.0003
749 DIABETES MELLITUS 23 0.0003
750 DYSMENORRHOEA 4 0.0003
751 UPPER LIMB FRACTURE 6 0.0003
752 LIP SWELLING 10 0.0003
753 PNEUMONIA 97 0.0003
754 GAIT INABILITY 10 0.0003
755 SUICIDAL IDEATION 27 0.0003
756 RESPIRATORY ARREST 8 0.0003
757 ACNE 22 0.0003
758 PARANOIA 5 0.0003
759 SYNCOPE 29 0.0003
760 NASAL CONGESTION 17 0.0003
761 MULTI-ORGAN FAILURE 5 0.0003
762 CONSTIPATION 63 0.0003
763 DIVERTICULITIS 8 0.0003
764 SWOLLEN TONGUE 9 0.0003
765 COMPLETED SUICIDE 24 0.0003
766 COORDINATION ABNORMAL 4 0.0003
767 INFUSION RELATED REACTION 19 0.0003
768 DERMATITIS 6 0.0003
769 LOWER RESPIRATORY TRACT INFECTION 13 0.0003
770 EOSINOPHILIA 5 0.0003
771 DEPRESSED MOOD 15 0.0003
772 BRONCHITIS 21 0.0003
773 HYPERTENSION 60 0.0003
774 OSTEOARTHRITIS 12 0.0003
775 BLOOD TRIGLYCERIDES INCREASED 5 0.0003
776 OSTEONECROSIS OF JAW 7 0.0003
777 PRODUCT DOSE OMISSION IN ERROR 8 0.0003
778 IMPAIRED WORK ABILITY 6 0.0003
779 CEREBRAL HAEMORRHAGE 10 0.0003
780 ANGINA PECTORIS 8 0.0003
781 HYPOACUSIS 12 0.0003
782 GOUT 5 0.0003
783 EYE IRRITATION 16 0.0003
784 BLOOD CREATINE PHOSPHOKINASE INCREASED 8 0.0003
785 CELLULITIS 14 0.0003
786 MEMORY IMPAIRMENT 38 0.0003
787 COMPLICATION OF DEVICE REMOVAL 5 0.0003
788 MENTAL DISORDER 12 0.0003
789 COMPLICATION ASSOCIATED WITH DEVICE 4 0.0003
790 FEELING ABNORMAL 66 0.0003
791 DRUG EFFECT INCOMPLETE 10 0.0003
792 PELVIC PAIN 5 0.0003
793 CLOSTRIDIUM DIFFICILE INFECTION 6 0.0003
794 BLOOD GLUCOSE ABNORMAL 5 0.0003
795 VIRAL INFECTION 9 0.0003
796 INJURY 19 0.0003
797 HAEMATOMA 7 0.0003
798 CONTUSION 26 0.0003
799 DIARRHOEA 174 0.0003
800 DEAFNESS 7 0.0003
801 WHITE BLOOD CELL COUNT DECREASED 29 0.0003
802 SNEEZING 6 0.0003
803 ARTHRALGIA 111 0.0003
804 HEPATIC CIRRHOSIS 5 0.0003
805 HEPATIC ENZYME INCREASED 18 0.0003
806 STOMATITIS 16 0.0003
807 CHEST DISCOMFORT 27 0.0003
808 BLOOD URINE PRESENT 5 0.0003
809 DRUG DISPENSING ERROR 4 0.0003
810 HERPES ZOSTER 15 0.0003
811 PAIN 160 0.0003
812 LOWER LIMB FRACTURE 5 0.0003
813 INSOMNIA 69 0.0003
814 RASH MACULAR 9 0.0003
815 JOINT SWELLING 31 0.0003
816 SWELLING 24 0.0003
817 HEART RATE DECREASED 9 0.0003
818 PRODUCT DOSE OMISSION ISSUE 75 0.0003
819 LYMPHADENOPATHY 9 0.0003
820 THERAPY CESSATION 13 0.0003
821 COUGH 71 0.0003
822 ACTIVITIES OF DAILY LIVING IMPAIRED 5 0.0003
823 SINUS DISORDER 5 0.0003
824 ABNORMAL BEHAVIOUR 10 0.0003
825 COMPLICATION OF DEVICE INSERTION 5 0.0003
826 INFLUENZA 28 0.0003
827 MULTIPLE SCLEROSIS 12 0.0003
828 ABSCESS 4 0.0003
829 ABDOMINAL PAIN 58 0.0002
830 PRODUCT ADMINISTRATION ERROR 5 0.0002
831 HOSPITALISATION 38 0.0002
832 DEVICE BREAKAGE 10 0.0002
833 DEEP VEIN THROMBOSIS 16 0.0002
834 OEDEMA PERIPHERAL 30 0.0002
835 SWELLING FACE 16 0.0002
836 INTENTIONAL DOSE OMISSION 7 0.0002
837 LIVER INJURY 6 0.0002
838 NASOPHARYNGITIS 45 0.0002
839 OSTEONECROSIS 8 0.0002
840 OSTEOPOROSIS 10 0.0002
841 ABASIA 6 0.0002
842 NEUTROPENIA 33 0.0002
843 BURNING SENSATION 17 0.0002
844 CYTOMEGALOVIRUS INFECTION 4 0.0002
845 AGEUSIA 6 0.0002
846 ABDOMINAL DISTENSION 25 0.0002
847 SKIN DISCOLOURATION 11 0.0002
848 ASCITES 7 0.0002
849 UNEVALUABLE EVENT 18 0.0002
850 RHEUMATOID ARTHRITIS 27 0.0002
851 LABORATORY TEST ABNORMAL 7 0.0002
852 SKIN EXFOLIATION 20 0.0002
853 PLATELET COUNT DECREASED 25 0.0002
854 RETCHING 5 0.0002
855 RESPIRATORY DISORDER 7 0.0002
856 ADVERSE DRUG REACTION 21 0.0002
857 GASTRIC DISORDER 8 0.0002
858 UNDERDOSE 17 0.0002
859 RECTAL HAEMORRHAGE 10 0.0002
860 POOR QUALITY SLEEP 5 0.0002
861 HYPERSENSITIVITY 43 0.0002
862 BLISTER 13 0.0002
863 INFLUENZA LIKE ILLNESS 19 0.0002
864 INCORRECT PRODUCT ADMINISTRATION DURATION 5 0.0002
865 CEREBROVASCULAR ACCIDENT 39 0.0002
866 ARTHRITIS 18 0.0002
867 DYSGEUSIA 17 0.0002
868 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 41 0.0002
869 RASH 99 0.0002
870 HYPOGLYCAEMIA 11 0.0002
871 DIABETES MELLITUS INADEQUATE CONTROL 4 0.0002
872 GENERAL PHYSICAL HEALTH DETERIORATION 26 0.0002
873 JAUNDICE 6 0.0002
874 TREMOR 37 0.0002
875 THROAT TIGHTNESS 6 0.0002
876 PNEUMONITIS 6 0.0002
877 PRODUCT AVAILABILITY ISSUE 5 0.0002
878 BONE DISORDER 4 0.0002
879 HAEMATOCHEZIA 12 0.0002
880 ABNORMAL DREAMS 6 0.0002
881 INTENTIONAL PRODUCT MISUSE 19 0.0002
882 INJECTION SITE MASS 8 0.0002
883 ARTHROPATHY 12 0.0002
884 WITHDRAWAL SYNDROME 9 0.0002
885 MUSCLE SPASMS 39 0.0002
886 PAIN IN JAW 6 0.0002
887 URINARY RETENTION 7 0.0002
888 PRODUCT SUBSTITUTION ISSUE 12 0.0002
889 DRUG PRESCRIBING ERROR 4 0.0002
890 MALAISE 90 0.0002
891 DYSPHONIA 12 0.0002
892 CHOKING 4 0.0002
893 BONE PAIN 12 0.0002
894 DISABILITY 4 0.0002
895 HYPERHIDROSIS 26 0.0002
896 NEOPLASM PROGRESSION 7 0.0002
897 THROAT IRRITATION 9 0.0002
898 PRODUCT DOSE OMISSION 13 0.0002
899 ABDOMINAL PAIN LOWER 5 0.0002
900 NEUTROPHIL COUNT DECREASED 8 0.0002
901 FEELING HOT 12 0.0002
902 HEPATITIS 5 0.0002
903 MOBILITY DECREASED 14 0.0002
904 EMOTIONAL DISORDER 6 0.0002
905 ERYTHEMA 40 0.0002
906 FEMUR FRACTURE 6 0.0002
907 EXPOSURE VIA SKIN CONTACT 5 0.0002
908 CARDIAC DISORDER 18 0.0002
909 HAEMORRHAGE 20 0.0002
910 ROAD TRAFFIC ACCIDENT 8 0.0002
911 MUCOSAL INFLAMMATION 5 0.0002
912 JOINT STIFFNESS 5 0.0002
913 OVERDOSE 41 0.0002
914 MULTIPLE SCLEROSIS RELAPSE 13 0.0002
915 RASH ERYTHEMATOUS 9 0.0002
916 MOOD SWINGS 6 0.0002
917 BLOOD GLUCOSE DECREASED 9 0.0002
918 MOVEMENT DISORDER 6 0.0002
919 INTESTINAL OBSTRUCTION 7 0.0002
920 FREQUENT BOWEL MOVEMENTS 5 0.0002
921 URTICARIA 31 0.0002
922 COLITIS 7 0.0002
923 ADVERSE EVENT 17 0.0002
924 ALOPECIA 36 0.0002
925 DYSPEPSIA 18 0.0002
926 IMPAIRED HEALING 6 0.0002
927 NO ADVERSE EVENT 33 0.0002
928 THERAPY INTERRUPTED 13 0.0002
929 PERIPHERAL SWELLING 28 0.0002
930 ILL-DEFINED DISORDER 11 0.0002
931 ANAPHYLACTIC REACTION 10 0.0002
932 PROCEDURAL PAIN 5 0.0002
933 SKIN DISORDER 6 0.0002
934 RED BLOOD CELL COUNT DECREASED 5 0.0002
935 RENAL DISORDER 8 0.0002
936 CHILLS 20 0.0002
937 BLOOD GLUCOSE INCREASED 31 0.0002
938 INJECTION SITE RASH 5 0.0002
939 HOT FLUSH 12 0.0002
940 CARDIOVASCULAR DISORDER 4 0.0002
941 THERAPEUTIC PRODUCT EFFECT DECREASED 7 0.0002
942 DEVICE ISSUE 14 0.0002
943 MUSCULOSKELETAL PAIN 8 0.0002
944 CHOLELITHIASIS 5 0.0002
945 EXPIRED PRODUCT ADMINISTERED 5 0.0002
946 EYE PRURITUS 5 0.0001
947 SUICIDE ATTEMPT 9 0.0001
948 EXTRA DOSE ADMINISTERED 6 0.0001
949 BLOOD BILIRUBIN INCREASED 4 0.0001
950 FLUSHING 15 0.0001
951 NIGHTMARE 5 0.0001
952 FLATULENCE 8 0.0001
953 PRURITUS 54 0.0001
954 MYELOSUPPRESSION 5 0.0001
955 DEATH 119 0.0001
956 DEVICE DISLOCATION 6 0.0001
957 INJECTION SITE HAEMORRHAGE 11 0.0001
958 MYOCARDIAL INFARCTION 24 0.0001
959 MYALGIA 23 0.0001
960 INJECTION SITE BRUISING 10 0.0001
961 INTENTIONAL OVERDOSE 8 0.0001
962 EMOTIONAL DISTRESS 15 0.0001
963 LUNG NEOPLASM MALIGNANT 5 0.0001
964 INJECTION SITE SWELLING 9 0.0001
965 MALIGNANT NEOPLASM PROGRESSION 12 0.0001
966 VAGINAL HAEMORRHAGE 5 0.0001
967 ECZEMA 6 0.0001
968 INJECTION SITE ERYTHEMA 14 0.0001
969 DRY SKIN 15 0.0001
970 ACCIDENTAL OVERDOSE 4 0.0001
971 INTERSTITIAL LUNG DISEASE 5 0.0001
972 PRODUCT QUALITY ISSUE 14 0.0001
973 INJECTION SITE REACTION 7 0.0001
974 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 7 0.0001
975 DISCOMFORT 6 0.0001
976 DRUG DOSE OMISSION 16 0.0001
977 INCORRECT DOSE ADMINISTERED 22 0.0001
978 INJECTION SITE PAIN 29 0.0001
979 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 19 0.0001
980 INJECTION SITE PRURITUS 6 0.0001
981 BLOOD CHOLESTEROL INCREASED 4 0.0001
982 PSORIASIS 11 0.0001
983 PRODUCT STORAGE ERROR 7 0.0001
984 DERMATITIS ATOPIC 4 0.0001
985 BREAST CANCER 7 0.0001
986 SKIN BURNING SENSATION 5 0.0001
987 ACCIDENTAL EXPOSURE TO PRODUCT 7 0.0001
988 DEVICE EXPULSION 4 0.0001
989 DEVICE DIFFICULT TO USE 4 0.0001
990 DRUG WITHDRAWAL SYNDROME 4 0.0000